COMPANY

NanoViricides

Keywords: infectious disease Ebola virus disease long COVID influenza

Location: Shelton, CT · source · Oct 14, 2026

Profile checked Oct 10, 2026

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

2026-02-25 Raise Private raise (SEC Form D): $6.0M sold; issuer “NANOVIRICIDES, INC.”. Verified from the SEC filing. SEC filing ↗

SEC Form D raise Raised $6M (Form D filed Feb 25, 2026). SEC Form D 0001104659-26-019284 (Feb 25, 2026)
Evidence (1 event)
- Feb 25, 2026 · SEC Form D 0001104659-26-019284
  Name of Issuer: NANOVIRICIDES, INC.; CIK: 1379006; Address: Shelton, CT; Submission type: D; Filing date: 2026-02-25; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-12; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 6000000; Total Amount Sold: 6000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals